Skip to main content
JHS Svendgaard Laboratories Ltd. logo

JHS Svendgaard Laboratories Ltd. — Investor Relations & Filings

Ticker · JHS ISIN · INE544H01014 LEI · 335800NYNAOOMRTTWW75 BSE.NS Manufacturing
Open in API
Filings indexed 678 across all filing types
Latest filing 2025-11-10 Regulatory Filings
Country IN India
Listing BSE.NS JHS

About JHS Svendgaard Laboratories Ltd.

https://www.svendgaard.com/

JHS Svendgaard Laboratories Ltd. is a specialized manufacturer of oral care products, operating primarily through contract manufacturing and private labeling arrangements. The company provides end-to-end solutions for oral hygiene, including the production of toothbrushes, toothpastes, mouthwashes, and specialized dental care items. It maintains large-scale manufacturing facilities equipped to handle high-volume production for global and domestic FMCG brands. In addition to its business-to-business operations, the company manages its own consumer brand, Aquawhite, which focuses on innovative oral care solutions for various age groups, including a significant range of licensed character-based products for children. The organization emphasizes quality control and technical expertise in oral health product development, catering to diverse market segments through a robust supply chain and distribution network.

Recent filings

Filing Released Lang Actions
Board Meeting — Board Meeting Intimation
Regulatory Filings
2025-11-10 English
Board Meeting — Financial Results
Regulatory Filings Classification · 95% confidence The document is a formal notice addressed to stock exchanges regarding the rescheduling of a Board Meeting to consider and approve the Un-Audited Standalone and Consolidated Financial Results for the quarter and half year ended September 30, 2025. It also mentions the closure of the trading window as per insider trading regulations. The document does not contain the financial results themselves but is an announcement about the timing of the meeting where results will be approved. The document length is short (1815 characters) and it serves as an intimation or notice rather than the actual financial report. Therefore, it fits the category of a Regulatory Filing (RNS) as a general regulatory announcement and compliance notice rather than an Interim Report (IR) or Earnings Release (ER).
2025-11-10 English
Board Meeting — Board Meeting Intimation
Regulatory Filings
2025-11-07 English
Board Meeting — Financial Results
Regulatory Filings Classification · 95% confidence The document is a formal notice addressed to stock exchanges about an upcoming Board of Directors meeting scheduled for November 13, 2025. The purpose of the meeting is to consider and approve the Un-Audited Financial Results for the quarter and half year ended September 30, 2025. The document also mentions the closure of the trading window in compliance with insider trading regulations. The document does not contain the financial results themselves but is an announcement of when these results will be approved and released. The document length is short (1888 characters) and it serves as an intimation or notification rather than the actual financial report. Therefore, it fits the category of Regulatory Filings (RNS), which is used for general regulatory announcements and compliance documents that do not contain substantive financial data or the report itself.
2025-11-07 English
General Updates
Regulatory Filings Classification · 95% confidence The document is an official communication from JHS Svendgaard Laboratories Limited to the Bombay Stock Exchange and National Stock Exchange of India, informing them about a warning letter received from these exchanges. The warning letter pertains to non-compliance with Regulation 20(3) of SEBI Listing Obligations and Disclosure Requirements (LODR) Regulations, specifically about the absence of the Chairperson of the Stakeholders Relationship Committee at the Annual General Meeting held in September 2024. The document includes the warning letter text and a summary annexure. There are no financial statements, management discussion, or detailed report content. The document is a regulatory announcement about a compliance issue and warning, not a financial report or management report. It fits best under Regulatory Filings (RNS) as it is a compliance-related disclosure and does not contain financial data or detailed report content. The document length (5675 characters) and content confirm it is not a report publication announcement or a full report.
2025-10-15 English
Certificate under SEBI (Depositories and Participants) Regulations, 2018
Regulatory Filings Classification · 95% confidence The document is a certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, related to the dematerialization of physical share certificates for the quarter ending September 30, 2025. It is a compliance certificate issued by the Registrar & Share Transfer Agent to the company and submitted to stock exchanges. The document does not contain financial statements, management discussion, or detailed report content. It is a regulatory compliance filing confirming share certificate cancellation and dematerialization. The document length is short (2476 characters) and it is a certificate, not a report or announcement of a report. Therefore, it fits best under Regulatory Filings (RNS) as a compliance certificate filing.
2025-10-14 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.